The invention provides methods for treating multiple sclerosis by administering biotin. The invention also provides methods for treating sequalae after multiple sclerosis attacks by administering biotin.

The invention relates to the use of biotin for treating multiple sclerosis, in particular of the progressive forms and of the neurological sequelae.

The present invention concerns a pharmaceutical composition comprising, by way of active substances: - papaverine, or one of the pharmaceutically acceptable salts thereof, and - at least one calcium antagonist from the class of dihydropyridines, or a pharmaceutically acceptable salt thereof

L'invention se rapporte à de nouvelles compositions pharmaceutiques fortement dosées en biotine, ainsi qu'à leur utilisation dans le traitement de déficiences visuelles, notamment liées à des atrophies optiques.

The invention relates to novel pharmaceutical compositions highly dosed with biotin, as well as to the use thereof in treating visual impairments which are related, in particular, to optic atrophy.